Invasion capabilities, assessed via Transwell assays, revealed a marked reduction in the invasive potential of cancer cells following RPL14 knockdown, pointing to its pivotal role in facilitating gastric cancer cell invasion (p < 0.001, Figure 9C). The gene discussed is RPL14; the disease is cancer.